...
首页> 外文期刊>European Journal of Nuclear Medicine and Molecular Imaging >~(99m)Tc-MIBI scintigraphy for early detection of locally recurrent non-small cell lung cancer treated with definitive radiation therapy
【24h】

~(99m)Tc-MIBI scintigraphy for early detection of locally recurrent non-small cell lung cancer treated with definitive radiation therapy

机译:〜(99m)Tc-MIBI闪烁体显像技术早期检测确定性放射治疗的局部复发性非小细胞肺癌

获取原文
获取原文并翻译 | 示例

摘要

After radiation therapy of lung cancer, a dense fibrotic shadow develops in the irradiated lung. Owing to this fibrosis, early detection of local recurrence after treatment is sometimes difficult even when using computed tomography (CT) and magnetic resonance imaging. We investigated the diagnostic accuracy of techne-tium-~(99m) hexakis 2-methoxyisobutylisonitrile (~(99m)Tc-MIBI) scintigraphy for the detection of recurrent lung cancer following definitive radiation therapy. Eighteen patients with primary non-small cell lung cancer treated with radiation therapy 1 year previously were studied with ~(99m)Tc-MIBI scintigraphy. They showed no evidence of local recurrence on serial chest radiographs. All single-photon emission tomography (SPET) images acquired 2 h after intravenous administration of the radio-pharmaceutical were visually interpreted with knowledge of the pretreatment chest radiograph, CT and the details of radiation therapy (radiation portals and administered doses). A region of interest (ROI) analysis was also performed. In addition to the ROI ratio of tumour uptake to accumulation in contralateral normal lung (tumour/lung ratio), another semiquantitative analysis, the ratio of tumour uptake to accumulation in radiation fibrosis (tumour/fibrosis ratio), was performed to differentiate between accumulation in radiation fibrosis and the tumour uptake. The scintigraphic diagnoses were correlated with clinical outcome. The sensitivity, specificity and negative predictive value of ~(99m)Tc-MIBI scintigraphy for the detection of recurrent lung cancer were all 88.9% (8/9). The tumour/lung ratios (mean+-SEM) of the nine patients with local recurrence and the other eight without local failure were 2.00+-0.11 and 1.40+-0.09, respectively (P<0.01). The tumour/fibrosis ratios of the patients with and those without recurrence were 1.47+-0.08 and 0.93+-0.05, respectively (P<0.01). These results suggest that ~(99m)Tc-MIBI scintigraphy might be of value for the detection of recurrent lung cancer, and especially of small foci in areas of radiation fibrosis that are hardly noticeable on serial chest radiographs.
机译:在对肺癌进行放射治疗后,被辐照的肺部会形成密集的纤维化阴影。由于这种纤维化,即使使用计算机断层扫描(CT)和磁共振成像,有时也很难早期发现治疗后的局部复发。我们调查了-〜(99m)六烷基2-甲氧基异丁腈(〜(99m)Tc-MIBI)闪烁显像技术对确定性放射治疗后复发性肺癌的诊断准确性。对〜一年(99m)Tc-MIBI闪烁显像技术研究了18例一年前接受放射治疗的原发性非小细胞肺癌患者。他们在连续的胸部X光片上没有显示出局部复发的证据。静脉内注射放射性药物后2小时获取的所有单光子发射断层扫描(SPET)图像均通过了解预处理胸片,CT和放射治疗的详细信息(放射门和给药剂量)进行视觉解释。还进行了感兴趣区域(ROI)分析。除了对侧正常肺中肿瘤吸收与累积的ROI比率(肿瘤/肺比率)以外,还进行了另一项半定量分析,即放射纤维化中肿瘤吸收与累积的比率(肿瘤/纤维化比率),以区分肿瘤的累积。放射纤维化和肿瘤吸收。闪烁显像诊断与临床结果相关。 〜(99m)Tc-MIBI闪烁显像对复发性肺癌的敏感性,特异性和阴性预测值均为88.9%(8/9)。 9例局部复发患者和其他8例无局部衰竭患者的肿瘤/肺比(mean + -SEM)分别为2.00 + -0.11和1.40 + -0.09(P <0.01)。有和没有复发的患者的肿瘤/纤维化比率分别为1.47 + -0.08和0.93 + -0.05(P <0.01)。这些结果表明,〜(99m)Tc-MIBI闪烁体显像可能对检测复发性肺癌,尤其是在连续性胸部X线片上几乎不可见的放射纤维化区域中的小灶灶具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号